Adherence and patients' experiences with the use of capecitabine in cancer treatment: The exploration of factors affecting the use in daily practice

Adherence and patients' experiences with the use of capecitabine in cancer treatment: The exploration of factors affecting the use in daily practice - Adherence and patients* experiences with capecitabine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36444

Enrollment

Registered

2009-12-08

Start date

2010-02-09

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer gastric cancer and breast cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Cancer patients starting with capecitabine

Exclusion criteria

Exclusion criteria: younger than 18 year

Design outcomes

Primary

Measure	Time frame
Adherence rate; a patient is adherent with the intake of 85% or more of the prescribed medication.	—

Secondary

Measure	Time frame
Number and grade of side-effects according to patients experience Attitude towards disease Beliefs and attitude towards medicines	—

Countries

Netherlands

Outcome results